SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
-----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
March 18, 2003
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 1-4389 06-1534213
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File No.) Identification No.)
301 Merritt 7
Norwalk, Connecticut 06851
(Address of principal executive offices, including Zip Code)
(203) 840-2000
(Registrant's telephone number, including area code)
Item 5. Other Events and Regulation FD Disclosure.
Attached hereto as Exhibit 99 and incorporated by reference herein is
the text of Applera Corporation's (the "Company") press release issued March 18,
2003, in which the Company's Applied Biosystems Group addresses current business
conditions.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibit is filed with this Report:
Exhibit No. Description
99 Press Release issued March 18, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLERA CORPORATION
By: /s/ Dennis L. Winger
------------------------------
Dennis L. Winger
Senior Vice President and
Chief Financial Officer
Dated: March 18, 2003
EXHIBIT INDEX
Exhibit No. Description
99 Press Release issued March 18, 2003.